"The price of greatness is responsibility." Sir Winston Churchill


Search the IBPA



IBPA Issues
About IBPA
IBPA Constitution
FAQ-s
IBPA Events
Individual Membership
Institutional Membership
IBPA Forums / Groups
Cooperation with IBPA
Links

Publications
IBPA Careers Newsletter
Past Issues
Industry Publications
Promote Yourself within the Industry
Submit Your Article

Career Center: Employers
Job Posting
Free Resume Database
Volunteers Database

Career Center: Job Seekers
Now Hiring
Submit Resume
Career Training
Nurses Careers in Biopharm
Scholarship Programs
Internship Programs
Resume Editing & Interview Coaching
Volunteer for the Industry
Download IBPA Career Info Brochure

Industry Directories and Listings
Pharmaceutical Companies
Contract Research Organizations
Professional Associations
Recruiters and Staffing Agencies
Clinical Research Centers
Consulting Companies
Education & Training Institutions
Jobs and Resume Searching Directories
Research and Development Companies
List Your Company

Investor's Center
Offers
Calls

Contact IBPA
US Chapter
Canadian Chapter
European Chapter
Asian Chapter

Start Your Career in Biotech with IBPA Scholarship Programs
Untitled Document



Subscribe to our "Careers in the Biopharmaceutical Industry" newsletter:

Name*:

Email*:

City:

Country:

Phone:

To unsubscribe, click here

 

 

Ancestry-informative marker

From Wikipedia, the free encyclopedia

 

An ancestry-informative marker (AIM) is a gene, generally of humans, which have several polymorphisms that exhibit substantially different frequencies between races. For example, the Duffy Null allele (FY*0) has a frequency of almost 100% of Sub-Saharan Africans, but occurs very infrequently in other races. A person having this gene is thus very likely to have some African ancestors. By using a number of AIMs one can estimate the ancestral (racial) proportion of an individual, as well as confidence intervals of the estimates. By using a suite of these markers more or less evenly spaced across the genome, they can be used in a cost-effective way to discover novel genes underlying complex diseases in a technique called admixture mapping or "mapping by admixture linkage disequilibrium". A collection of AIMs that distinguish African and European populations contains 3011 highly differentiated SNP's. [1]

[edit]

 

References

  • DNAtesting [2]
  • Shriver, Mark D. et al., "Skin pigmentation, biogeographical ancestry and admixture mapping," Hum. Genet. 112, 387-399 (2003)[3]



External links




Learn More About the Biopharmaceutical Industry and Clinical Research:


Category:


Powered by Wikipedia, the free encyclopedia. Articles were developed by IBPA volunteers.

A

B

C

D

E

F

G

I

K

L

M

N

P

Q

R

S

T


©2004 International Biopharmaceutical Association Inc., all rights reserved
Privacy Policy - Terms of Use

Google